Mutant prevention concentration of ozenoxacin for quinolone-susceptible or -resistant Staphylococcus aureus and Staphylococcus epidermidis

Ozenoxacin (OZN) belongs to a new generation of non-fluorinated quinolones for the topical treatment of skin infections which has shown to be effective in the treatment of susceptible and resistant Gram-positive cocci. The mutant prevention concentration (MPC) of ozenoxacin, levofloxacin and ciprofl...

Descripción completa

Detalles Bibliográficos
Autores principales: López, Y., Tato, M., Gargallo-Viola, D., Cantón, R., Vila, J., Zsolt, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785070/
https://www.ncbi.nlm.nih.gov/pubmed/31596898
http://dx.doi.org/10.1371/journal.pone.0223326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785070/
https://www.ncbi.nlm.nih.gov/pubmed/31596898
http://dx.doi.org/10.1371/journal.pone.0223326

Ejemplares similares